Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by CURTIS, L. R.
Right arrow Articles by CARPENTER, H. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by CURTIS, L. R.
Right arrow Articles by CARPENTER, H. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1990 Oxford University Press

other

2,3,7,8-Tetrachlorodibenzo-p-dioxin Pretreatment of Female Mice Altered Tissue Distribution but Not Hepatic Metabolism of a Subsequent Dose

LAWRENCE R. CURTIS*, NANCY I. KERKVLIET{dagger}, LINDA BAECHER-STEPPAN{dagger} and HILLARY M. CARPENTER*

*Oak Creek Laboratory of Biology, Department of Fisheries and Wildlife Corvallis, Oregon 97331 {dagger}College of Veterinary Medicine, Oregon State University Corvallis, Oregon 97331

Received May 22, 1989; accepted September 11, 1989

2,3,7,8-Tetrachlorodibenzo-p-dioxin Pretreatment of Female Mice Altered Tissue Distribution but Not Hepatic Metabolism of a Subsequent Dose. CURTIS, L. R., JCERKVLIET, N. I., BAECHER-STEPPAN, L., AND CARPENTER, H. M. (1990). Fundam. Appl. Toxicol 14, 523–531. Lipid partitioning of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inadequately explains its tissue distribution since higher concentrations occur in liver than fat except at high doses. This study provides In vivo evidence that an inducible, saturable system plays a predominant role in disposition of [14C]TCDD in female mice at doses between 5 and 20 Mg/kg. Female C57BL/6J mice were gavaged with 0, 5, or 15 µg, TCDD/kg, received a subsequent gavage of 5 or 20 11% [14C]TCDD after 6 days, and were killed 1 day later. In mice pretreated with 5 and 15MgTCDD/ kg and subsequently dosed with 20 µg [14C]TCDD/kg, liver weight and [14C]TCDD concentration increased. Total liver [14C]TCDD burden increased about 50% in both pretreatment groups. Concentrations of [14C]TCDD in kidney, fat, heart, lung, gastrointestinal tract, but not plasma or splenic lymphocytes, decreased in a reciprocal manner. Alterations in absorption, concentrations of polar metabolites of [14C]TCDD in liver, and hepatic lipid content failed to explain these results. About 97% of hepatic 14C was hexane extractable. HPLC of this extract indicated [14C]TCDD was the only significant nonpolar form of radiolabel in liver. In mice pretreated with 511% TCDD/kg and subsequently dosed with 5 µg [14C]TCDD/kg, a more marked pretreatment disposition response was observed. These results are consistent with a predominant role for an inducible, high affinity, low capacity system in whole animal pharmacokinetics of TCDD.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.